fbpx Dr Wild re-elected | Science in the net

Dr Wild re-elected

Primary tabs

Pubblicato il 21/05/2013Read time: 2 mins

The International Agency for Research on Cancer (IARC) has the pleasure of announcing the re-election of Dr Christopher Wild as Director of this specialized cancer research agency of the World Health Organization (WHO). The IARC Governing Council, made up of representatives of 24 Participating States plus the Director-General of WHO, reappointed Dr Wild for a second five-year term at its annual meeting in Lyon on May 16–17, 2013.

“I have had the honour and privilege to lead IARC for five years, and I look forward to taking up the challenges posed by the markedly increasing number of cancer cases globally,” said Dr Wild. “The particularly heavy burden projected to fall on the low- and middle-income countries makes it implausible to treat our way out of this disease. This is why the Agency will continue to work for cancer prevention in the coming years, all the way from identifying the causes through to evaluating interventions.”

Brazil and Qatar became the two newest IARC Participating States during the Governing Council meeting. Dr Wild noted the importance of this, stating, “The presence of Brazil and Qatar means that two new regions of the world are represented on our governing body. This sends a strong signal that IARC’s remit is a global one, conducted in partnership with the emerging strengths and leadership in cancer research worldwide.”

Dr Wild, a former Professor of Molecular Epidemiology and Director of the Leeds Institute of Genetics, Health and Therapeutics (LIGHT), was first appointed Director of IARC in May 2008; he took office on 1 January 2009.

Autori: 
di redazione
Sezioni: 
News
Director of IARC
  • 5805 reads

prossimo articolo

My Portrait of Anthony Fauci

di Guido Poli
Pubblicato il 05/08/2026

Anthony Fauci, at 85, has been called to testify before the Senate committee investigating the origins of the Covid-19 pandemic, in what feels like a settling of scores by the very party that, at the time, was recommending chloroquine as a defence. The eminent physician is once again at the centre of controversy, not least for choosing to invoke the Fifth Amendment rather than answer questions. Guido Poli, immunologist at the San Raffaele Hospital and president of Patto Trasversale per la Scienza, who worked with him for many years, recalls in this article Tony Fauci's battles in the history of American and international public health, from AIDS to the pandemic. The image is taken from the footage (public domain) of A. Fauci's hearing on 29 July 2026 before the Senate Homeland Security and Governmental Affairs Committee.

Global Health

In recent days, Anthony (“Tony”) Fauci has once again become a prominent figure in the international media, and to some extent in Italy as well. As the physician-scientist who has played one of the leading roles in U.S. public health over the past several decades, he became known throughout the world during the darkest days of the COVID-19 pandemic. Having had the privilege and good fortune to work with him from 1986 to 1993, I would like to offer my personal account of the scientist and the man.